Raymon Heather 4
4 · Artiva Biotherapeutics, Inc. · Filed Aug 18, 2025
Insider Transaction Report
Form 4
Raymon Heather
SVP, Research and Development
Transactions
- Tax Payment
Common Stock
2025-08-15$2.75/sh−1,639$4,507→ 40,966 total - Tax Payment
Common Stock
2025-05-15$2.13/sh−745$1,587→ 42,605 total
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards.